Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
4(100.0%)
4Total
Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05804383Phase 1Completed

A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease

Role: lead

NCT06632990Phase 1Active Not Recruiting

A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates

Role: lead

NCT05817643Phase 1Unknown

Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

Role: lead

NCT06309147Phase 1Recruiting

A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's

Role: lead

All 4 trials loaded